Survey of the Quality of Selected Antimalarial Medicines Circulating in Madagascar, Senegal, and Uganda
(2009; 50 pages)

Abrégé

This report presents the first findings from a collaborative study by the World Health Organization and the Drug Quality and Information (DQI) Program, supported by the United States Agency for International Development (USAID) and implemented by the U.S. Pharmacopeia (USP), on the quality of key antimalarial medicines in Sub-Saharan African countries (QAMSA Study). The QAMSA Study stands out from other studies for several reasons: the large number of medicines sampled based on a field-tested protocol; the large number of samples that were submitted to full-scale confirmatory quality control (QC) testing; and the different levels of the distribution chain from which the samples were obtained. The QAMSA Study covers 10 countries in total; the findings in this subject report focus on the three countries for which DQI was responsible—Madagascar, Senegal, and Uganda...

 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 25 juin 2014